12-07-2023 / Dr. Mina Wang, Senior Peptide Scientist, R&D Department, GenScript Biotech
As one of the most effective peptide modification strategies, cyclization imparts distinct biochemical and therapeutic properties to peptides for drug development, such as increased half-life and cell permeability.
Learn More
10-06-2023 / Dr. Guo Luo, Immunologist and Instructor, Stanford University School of Medicine
Join this webinar to learn about the adaptive immune response in narcolepsy type 1 (NT1), including peptide binding affinity to human leukocyte antigen (HLA), the isolation of antigen-HLA restricted CD4+ T cells, and single-cell RNA sequencing of CD4+ T c
Learn More
09-15-2023 / Dr. Robert Ford, Field Application Scientist, GenScript Biotech - Europe
Join us in our webinar to learn about optimizing enzyme manufacturing via an E. coli one-stop solution expression system, from enzyme discovery to conversion from RUO to GMP-grade requirements and facilitating a seamless transition
Learn More
04-18-2023 / Jonghyeok Ha, Technical Account Manager, GenScript Korea Ltd
Enhanced gene knock-in efficiency via non-viral gene edition using CRISPR/Cas platform
Learn More
03-27-2023 / Dr. Kai Hilpert, Associate Professor, St George's, University of London Founder and Director, TiKa Diagnostics
Discover new antimicrobial treatments focusing on AMPs with BioSAXS in our upcoming webinar. Dr. Kai will cover peptide synthesis, screening with spot synthesis on cellulose, and how BioSAXS can classify antimicrobials by mode of action.
Learn More
11-16-2022 / Yifan Yu, Ph.D. Senior Scientist, Product Manager of Cell Therapy Products
Enhance Your Cell and Gene Therapy Workflow with GenScript Tools
Learn More
08-16-2022 / Hao Tan, Ph.D. Head of Shanghai Cell Line and Virus Vector Development Department, GenScript
A Novel and Rapid Platform to Generate Gram-level Antibodies for Diagnostic and Therapeutic Use
Learn More
04-27-2022 / Dr. Jane Tan, Product Manager, GenScript
Enhance your Western Blot Workflow with Advanced Technology
Learn More